Government
Every published round Australian Research Council took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted, and a place in one of its own programs is under Cohorts.
Everyone Australian Research Council has named to a program in published coverage. A place in a program is not a raise: the cheque is the figure recorded with the place, which is the program's standard terms where we hold them, and a blank is one we don't.
| Member | Program | Announced | Cheque | Sources |
|---|---|---|---|---|
| Gerhard Swiegers | Industry Laureate Fellowship | 15 May 2023 | - | @AuManufacturing |
Companies Australian Research Council has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| No portfolio companies recorded yet. | ||||
Fund closes reported for Australian Research Council, as distinct from the investments it has made.
Companies Australian Research Council has backed that another company then bought. An exit for the holding, not a deal Australian Research Council did.
| Name | Role | Sources |
|---|---|---|
| Dr Carina Garland | MP | @AuManufacturing |
Stories naming Australian Research Council. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Breakthrough Victoria's release marks Infleqtion's New York Stock Exchange listing, the investor's first portfolio listing, and notes further quantum backing of Quantum Brilliance plus Infleqtion's Victorian operations and partnerships.
Also Breakthrough Victoria·Breakthrough Victoria·Breakthrough Victoria·Breakthrough Victoria·Startup Daily·SmartCompany
Australian nanobiotech firm Nexsen has begun trading on the sharemarket after an $8m IPO; earlier government grants and an RMIT research collaboration are also noted.
Breakthrough Victoria reflects on its 2022 investment in quantum company Infleqtion, part of a larger raise, detailing Victorian operations, university partnerships, workforce programs and a planned US listing via SPAC.
Sydney biotech Smart MCs and UNSW won Australian Research Council funding of $900,000 for microcarrier development; the company earlier joined Big Idea Ventures' accelerator, raised pre-seed, and received a 2023 government grant.
Starpharma, two universities, Telix, Clarity and CSIRO launch an ARC-backed radiopharmaceutical research hub with a government grant and industry funding.
Wollongong electrochemist Gerhard Swiegers has won an ARC Industry Laureate Fellowship with $3.7 million in funding for electrolyser research that underpins green hydrogen startup Hysata.
RenewEconomy reports HB11 Energy's bilateral research deal with Spanish laser labs and mentions its earlier $560,000 grant from ARC for a fusion laser project with UNSW and other universities.
A University of Queensland spinout has secured investment from Uniseed and an Indigenous-owned group to commercialise injectable medical gels made from spinifex grass fibres, building on earlier research funded by an Australian Research Council grant.
Roundup of Australian manufacturing news: Orbital UAV's $5m placement with UIL backing, Nufarm's record earnings, a Hazer–Mitsui graphite agreement, Baraja's patent milestone, the new skills agency, and a university research grant.
Roundup of manufacturing items: a training milestone at Nova Systems, Gilmour Space rocket work, a Lockheed Martin STEM program, an ATSE infrastructure statement, a steel research hub launch, and Queensland's new startup fund.
Horizon 3 Biotech, an Australian life sciences venture fund, announces Dr Tam Nguyen joining its investment committee, citing his board, research commercialisation and healthcare experience and past Brandon Capital secondment.
Deakin University's Institute for Frontier Materials received an ARC Linkage grant to work with HB11 Energy on proton-boron fusion and hydrogen storage; HB11 raised an oversubscribed pre-seed round in February 2021.
A roundup of short manufacturing items: Eden Innovations wins a research council grant for nanotube composites, Elsight announces a planned shareholder raise, and Envirostream shows crop nutrient results from recycled battery materials.
Snoretox, a RMIT University spin-off developing modified tetanus toxin drugs, announced it raised more than one million dollars to commercialise ToneTox and SnoreTox.
Relays an Australian Financial Review report that lung imaging company 4DMedical will list on the ASX at a $193 million market capitalisation, profiling founder Andreas Fouras and the technology's development.
Australian Research Council's final 2019 Linkage Project grant round awarded $35 million across 77 projects, including UNSW superalloy and battery-recycling work and University of Queensland graphene cathode research with industry partners.
Federal education minister Dan Tehan announced grants sharing $7.5 million across 18 collaborative projects under the ARC Linkage Program, including Curtin University research on exporting green hydrogen as a solid.
The latest federal Incubator Support grants went to six regional recipients, among them AgriStart, Arc, ThincLab and UNE's AgTech Gateway; past rounds funded Bega Valley Shire and Bridge Hub.
Also SmartCompany